A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer

Overview of attention for article published in BMC Cancer, July 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

reddit: 1 Redditor

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Reddit Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,290 followers.

A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer by Wanjun Yu https://t.co/tTrn2R9TBu

02 Aug 2021

Reply Repost Favourite

New article: A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer https://t.co/SvIvBgcIIx #lungcancer #oncology https://t.co/G93zGpGK1T

02 Aug 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.